Published in Clin Hemorheol Microcirc on January 01, 2006
CARDIOVASCULAR RISK ASSESSMENT AND SUPPORT TECHNIQUES: Whole blood viscosity assessment issues I: Extrapolation chart and reference values. N Am J Med Sci (2010) 1.17
Platelet function tests: a comparative review. Vasc Health Risk Manag (2015) 1.11
Whole blood viscosity determination in diabetes management: perspective in practice. N Am J Med Sci (2009) 1.07
Whole blood viscosity issues VI: Association with blood salicylate level and gastrointestinal bleeding. N Am J Med Sci (2010) 0.91
Determinants to optimize response to clopidogrel in acute coronary syndrome. Pharmgenomics Pers Med (2010) 0.87
Inconsistency of different methods for assessing ex vivo platelet function: relevance for the detection of aspirin resistance. Haematologica (2010) 0.80
Prognostic value of inflammatory mediators in 1-year outcome of acute ischemic stroke with middle cerebral artery stenosis. Mediators Inflamm (2013) 0.79
Effects of aspirin on rheological properties of erythrocytes in vitro. Int J Biomed Sci (2012) 0.75
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut (2012) 12.62
Adherence to Mediterranean diet and health status: meta-analysis. BMJ (2008) 4.16
Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr (2010) 3.99
Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. J Am Coll Cardiol (2007) 3.20
Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation. Circulation (2011) 2.60
Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI study. J Am Coll Cardiol (2013) 2.56
Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol (2010) 2.55
Long-term prognostic role of uric acid in patients with ST-elevation myocardial infarction and renal dysfunction. J Cardiovasc Med (Hagerstown) (2015) 2.30
Seasonal blood pressure changes: an independent relationship with temperature and daylight hours. Hypertension (2013) 2.30
Carotid artery stenting: first consensus document of the ICCS-SPREAD Joint Committee. Stroke (2006) 2.21
Physical activity during leisure time and primary prevention of coronary heart disease: an updated meta-analysis of cohort studies. Eur J Cardiovasc Prev Rehabil (2008) 2.14
Mechanical ventilation in the early phase of ST elevation myocardial infarction treated with mechanical revascularization. Cardiol J (2013) 2.06
Weather-related changes in 24-hour blood pressure profile: effects of age and implications for hypertension management. Hypertension (2005) 2.05
Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data. J Am Coll Cardiol (2011) 2.05
Strong-ion gap approach in patients with cardiogenic shock following ST-elevation myocardial infarction. Acute Card Care (2013) 2.03
Abnormal troponin level as short-term predictor of poor outcome in acute atrial fibrillation. Am J Emerg Med (2013) 2.02
Vascular Behçet's disease: new insights in the management of thrombosis. Expert Rev Cardiovasc Ther (2013) 2.00
Comparison of the degree of platelet aggregation inhibition with prasugrel versus clopidogrel and clinical outcomes in patients with unprotected left main disease treated with everolimus-eluting stents. Am J Cardiol (2013) 2.00
Cryptogenic myocardial infarction in young patients: which is the optimal diagnostic and therapeutic management? Arch Iran Med (2013) 1.99
Five-year echocardiographic results of combined undersized mitral ring annuloplasty and coronary artery bypass grafting for chronic ischaemic mitral regurgitation. Eur Heart J (2007) 1.93
EXCAVATOR: detecting copy number variants from whole-exome sequencing data. Genome Biol (2013) 1.90
Genome-wide association study of vitamin B6, vitamin B12, folate, and homocysteine blood concentrations. Am J Hum Genet (2009) 1.87
Analysis of minK and eNOS genes as candidate loci for predisposition to non-valvular atrial fibrillation. Eur Heart J (2006) 1.82
Lipoprotein (a) and venous thromboembolism in adults: a meta-analysis. Am J Med (2007) 1.76
Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment. Thromb Haemost (2009) 1.75
Prognostic value of 6-minute walk corridor test in patients with mild to moderate heart failure: comparison with other methods of functional evaluation. Eur J Heart Fail (2003) 1.70
Perioperative handling of patients on antiplatelet therapy with need for surgery. Intern Emerg Med (2009) 1.69
Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience. Int J Cardiol (2008) 1.66
Left ventricular reverse remodeling after undersized mitral ring annuloplasty in patients with ischemic regurgitation. Ann Thorac Surg (2008) 1.65
Assessment of cardiac output in children: a comparison between the pressure recording analytical method and Doppler echocardiography. Pediatr Crit Care Med (2008) 1.64
Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents. J Am Coll Cardiol (2008) 1.64
Increased plasma levels of lipoprotein(a) and the risk of idiopathic and recurrent venous thromboembolism. Am J Med (2003) 1.60
Phenotypic variability of cardiovascular manifestations in Marfan Syndrome. Possible role of hyperhomocysteinemia and C677T MTHFR gene polymorphism. Eur Heart J (2003) 1.59
Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years. J Am Coll Cardiol (2009) 1.58
Retinal vein occlusions: a review for the internist. Intern Emerg Med (2010) 1.57
Evaluation of traditional and emerging cardiovascular risk factors in patients with non-arteritic anterior ischemic optic neuropathy: a case-control study. Graefes Arch Clin Exp Ophthalmol (2008) 1.57
Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis. Am J Cardiol (2009) 1.57
The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial. J Am Coll Cardiol (2003) 1.54
Role of endothelin-1 in exposure to high altitude: Acute Mountain Sickness and Endothelin-1 (ACME-1) study. Circulation (2006) 1.54
An unusual case of cardiac tamponade. J Cardiovasc Med (Hagerstown) (2006) 1.53
[Non-alcoholic fatty liver disease: a new challenge for cardiologists]. G Ital Cardiol (Rome) (2010) 1.52
High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis. Am J Med (2002) 1.50
Residual platelet reactivity is an independent predictor of myocardial injury in acute myocardial infarction patients on antiaggregant therapy. Thromb Haemost (2007) 1.50